Takeda Pharmaceutical
TAK
#451
Rank
S$71.02 B
Marketcap
S$22.24
Share price
1.06%
Change (1 day)
20.46%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2026 (TTM): S$0.33 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are S$29.73 Billion. In 2025 the company made an earning of S$4.29 Billion, an increase over its 2024 earnings that were of S$2.88 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.33 B-92.22%
2025 S$4.29 B49.03%
2024 S$2.88 B-2.41%
2023 S$2.95 B-28.14%
2022 S$4.10 B-40.9%
2021 S$6.94 B78.24%
2020 S$3.89 B246.1%
2019 S$1.12 B-48.79%
2018 S$2.19 B-23.64%
2017 S$2.88 B21.7%
2016 S$2.36 B-253.01%
2015 -S$1.55 Billion-159.65%
2014 S$2.59 B13%
2013 S$2.29 B2.46%
2012 S$2.23 B-57.05%
2011 S$5.21 B-10.49%
2010 S$5.82 B-3.99%
2009 S$6.06 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.53 B 9,308.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$20.37 B 5,616.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$13.67 B 3,735.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$11.72 B 3,190.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.88 B 2,673.61%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$16.97 B 4,663.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$12.92 B 3,525.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-S$1.03 Billion-386.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
S$0.85 B 140.37%๐Ÿ‡ฎ๐Ÿ‡ณ India